Literature DB >> 1354445

Adverse effects of systemic opioid analgesics.

S A Schug1, D Zech, S Grond.   

Abstract

Adverse effects of opioids are multiple. They are most often receptor-mediated and inseparable from their desired effects. The most severe mishaps with opioids are related to their respiratory depressant effect, which is widely influenced by factors such as pain, previous opioid experience and awareness. Other relevant central nervous system effects of opioids include cough suppression, nausea and vomiting, rigidity, pruritus and miosis. The cardiovascular adverse effects of opioids are mainly related to histamine release and differ widely between agonists and agonist-antagonists. Gastrointestinal effects such as constipation, reflux and spasms of the bile duct are well described. Adverse effects on endocrine, immunological and haematological functions are possible, while allergic reactions are extremely rare. The adverse effects of long term use are overestimated. Systemic toxicity is negligible and development of tolerance is minimal while treating pain. In the clinical setting of pain control, addiction and withdrawal do not pose significant problems. Nevertheless, the possible effects of opioids on the unborn child should always be considered. Overall, opioids show a good record of safety. Their use should not be unduly limited by unfounded fears of adverse effects, but these effects should be avoided by anticipation and prevention.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354445     DOI: 10.2165/00002018-199207030-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  86 in total

1.  ELEVATION OF PLASMA HISTAMINE LEVELS IN THE DOG FOLLOWING ADMINISTRATION OF MUSCLE RELAXANTS, OPIATES AND MACROMOLECULAR POLYMERS.

Authors:  W L THOMPSON; R P WALTON
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

Review 2.  Opioids in chronic pain.

Authors:  H J McQuay
Journal:  Br J Anaesth       Date:  1989-08       Impact factor: 9.166

3.  The effects of drugs and anaesthetic agents on the urinary bladder and sphincters.

Authors:  P T Doyle; C E Briscoe
Journal:  Br J Urol       Date:  1976-10

4.  Normeperidine toxicity.

Authors:  P J Armstrong; A Bersten
Journal:  Anesth Analg       Date:  1986-05       Impact factor: 5.108

5.  Endorphins--a role in lower urinary tract function? The effect of opioid blockade on the detrusor and urethral sphincter mechanisms.

Authors:  K H Murray; R C Feneley
Journal:  Br J Urol       Date:  1982-12

6.  Fentanyl and convulsions.

Authors:  P S Sebel; J G Bovill
Journal:  Anesth Analg       Date:  1983-09       Impact factor: 5.108

7.  Changes in rib cage and diaphragm contribution to ventilation after morphine.

Authors:  J R Rigg; P Rondi
Journal:  Anesthesiology       Date:  1981-11       Impact factor: 7.892

8.  Suppression of human peripheral blood mononuclear cell function by methadone and morphine.

Authors:  P K Peterson; G Gekker; C Brummitt; P Pentel; M Bullock; M Simpson; J Hitt; B Sharp
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

9.  Common bile duct pressure changes after fentanyl, morphine, meperidine, butorphanol, and naloxone.

Authors:  P A Radnay; D Duncalf; M Novakovic; M L Lesser
Journal:  Anesth Analg       Date:  1984-04       Impact factor: 5.108

10.  Clinical pharmacokinetics applied to patients with intractable pain: studies with pethidine.

Authors:  Christopher J Glynn; Laurence E Mather
Journal:  Pain       Date:  1982-07       Impact factor: 6.961

View more
  31 in total

Review 1.  Acupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials.

Authors:  Tae-Young Choi; Myeong Soo Lee; Tae-Hun Kim; Christopher Zaslawski; Edzard Ernst
Journal:  Support Care Cancer       Date:  2012-03-25       Impact factor: 3.603

2.  Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation.

Authors:  Simona Patierno; Laura Anselmi; Ingrid Jaramillo; David Scott; Rachel Garcia; Catia Sternini
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

Review 3.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 4.  Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem.

Authors:  Kirsten Auret; Stephan A Schug
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Opioids for managing chronic non-malignant pain: safe and effective prescribing.

Authors:  Meldon Kahan; Anita Srivastava; Lynn Wilson; Angela Mailis-Gagnon; Deana Midmer
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

6.  Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.

Authors:  C Gavériaux-Ruff; H W Matthes; J Peluso; B L Kieffer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2018-06-28

8.  Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.

Authors:  F Simonin; O Valverde; C Smadja; S Slowe; I Kitchen; A Dierich; M Le Meur; B P Roques; R Maldonado; B L Kieffer
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

9.  Evaluation of buprenorphine in a postoperative pain model in rats.

Authors:  Leslie I Curtin; Julie A Grakowsky; Mauricio Suarez; Alexis C Thompson; Jean M DiPirro; Lisa B E Martin; Mark B Kristal
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

10.  [Ketamine racemate and fast track anaesthesia. Influence on recovery times and postoperative opioid needs].

Authors:  E A Lux; T Haack; K Hinrichs; E Mathejka; W Wilhelm
Journal:  Anaesthesist       Date:  2009-10       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.